Home > Financial Ratios > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 35.0529.8926.6019.6619.38

What is the latest EV/Core EBITDA ratio of TORRENT PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of TORRENT PHARMACEUTICALS is 35.05 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202635.05
Mar202529.89
Mar202426.60
Mar202319.66
Mar202219.38

How is EV/Core EBITDA of TORRENT PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2026 35.05
17.26
Mar2025 29.89
12.37
Mar2024 26.6
35.30
Mar2023 19.66
1.44
Mar2022 19.38 -

Other Financial Ratios of TORRENT PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹190,123.9 Cr 2.6% 3% 33.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -2.6% 2.4% 14.6% Stock Analytics
DIVIS LABORATORIES ₹221,666.0 Cr 6.5% 23.3% 25.3% Stock Analytics
CIPLA ₹117,139.0 Cr -1.1% -0.2% -7.9% Stock Analytics
MANKIND PHARMA ₹101,267.0 Cr -4.9% -3.1% -3.6% Stock Analytics
DR REDDYS LABORATORIES ₹97,990.9 Cr 2.6% -13.3% -10.7% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

2.6%

3%

33.5%

SENSEX

1.2%

0.4%

-2.9%


You may also like the below Video Courses